AzTrials
AzTrials

Incontinence, UrgeNCT05948397

To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence

An observational study of Incontinence, Urge and Incontinence Stress, run by Koç University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is detecting the dominant component of mixed urinary incontinence via a combined version of ICIQ-SF and quality of life scale. The main question it aims to answer is: 1. Which component (urgency or stress) urinary incontinence bothers the patient more? Read more about this study

Who is it for?
Ages 18 to 90 years, women onlyHealthy volunteers can take part
What is being tested?
Combined version of International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) and quality of life scale, Bladder diary and Pad test
How many people
100 participants
Where
No sites listed yet
Study dates
1 Aug 2023to 1 Aug 2025
How long will I take part?
1 Month
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Females with mixed urinary incontinence

Who may be able to join

  • Female patients above 18 years old with mixed urinary incontinence

Who cannot join

  • Non-Turkish speakers
  • Poor conscious level
  • Immobile patients

Trial locations and contacts

No sites are listed yet.

Tufan Tarcan, Prof contact

905434948365

bilgi@tufantarcan.com

Ersin Köseoğlu contact

905306930442

ersinkoseoglu@ku.edu.tr

About this study

The goal of this observational study is detecting the dominant component of mixed urinary incontinence via a combined version of ICIQ-SF and quality of life scale. The main question it aims to answer is:

  1. Which component (urgency or stress) urinary incontinence bothers the patient more?
Read the detailed description

Female patients with mixed urinary incontinence will be given a combined version of ICIQ-SF and quality of life scale on the first visit. Additionally, a bladder diary and 1-hour pad test will be performed on the same visit. After deciding the appropriate treatment, on the 1-month visit (second visit) the same tests will be repeated and scores will be compared.

Being tested
Combined version of International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) and quality of life scale, Bladder diary, Pad test
Medical subject headings
Urinary Incontinence, Urge, Urinary Incontinence, Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined version of International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) and quality of life scaleDiagnostic test

    A combined version of International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) and quality of life scale would be given to all patients. The sum of the responses for the third, fourth and fifth questions and quality of life scale scores will be recorded.

  • Bladder diaryDiagnostic test

    Bladder diary is an online application. Frequency, nocturia, functional bladder capacities will be reported. More than 8 urination during daytime will be recorded as overactive bladder. More than 1 interruption of sleep for urination at night is nocturia. Functional bladder capacity below 100 ml will be defined as decreased bladder capacity, while capacity over 400 ml will be reported as increased bladder capacity and compliance

  • Pad testDiagnostic test

    One-hour pad test.

    • the test is started by putting one pre-weighted pad without patient voiding, -patient drinks 500 ml of sodium-free liquid in <15 min- then sits or rests,
    • patient walks for 30 min, including climbing one flight of stairs (up and down),
    • patient performs the following activities: standing up from sitting (10 ), coughing vigorously (10 ), running on the spot for 1 min, bending to pick up an object from the floor (5 ), and washing hands in running water for 1 min (this activity program may be modified according to the patient's physical fitness),
    • the total amount of urine leaked is determined by weighing the pad. In the analysis of 1-hr pad test, an increase of 1-10 g is classified as representing mild incontinence, 11-50 g moderate and >50 g severe incontinence. The values for 24-hr pad test are classified as follows: Mild (4-20 g/ 24 hr), moderate (21-74 g/24 hr), and severe (>75 g/24 hr) incontinence
Study groups in NCT05948397
Study groupRoleWhat they receive
Study GroupFemale patients admitted to urology outpatient clinic with mixed urinary incontinence.
Receives: Diagnostic Test: Combined version of International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) and quality of life scale; Diagnostic Test: Bladder diary; Diagnostic Test: Pad test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. International Consultation on Incontinence Questionnaire Short Form

    Questionnaire

    Measured: 1 month

  2. Pad test

    Diagnostic Test

    Measured: 1 month

  3. Bladder diary

    Diagnostic Test

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2023
  2. Study start1 Aug 2023 (estimated)
  3. Primary completion1 Aug 2024 (estimated)
  4. Study completion1 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT05948397
Sponsor's protocol ID
KocUrol2
Status last verified
Jul 2023
First submitted
9 Jul 2023
Last updated
17 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Incontinence, Urge and Incontinence Stress, run by Koç University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tufan Tarcan, Prof (905434948365, bilgi@tufantarcan.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

International Consultation on Incontinence Questionnaire Short Form (time frame: 1 month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in